The
liver and the mammary gland have complementary metabolic roles
during lactation. Substrates synthesized by the liver are released
into the circulation and are taken up by the mammary gland for milk
production. The aryl hydrocarbon receptor (AHR) has been identified
as a lactation regulator in mice, and its activation has been associated
with myriad morphological, molecular, and functional defects such
as stunted gland development, decreased milk production, and changes
in gene expression. In this study, we identified adverse metabolic
changes in the lactation network (mammary, liver, and serum) associated
with AHR activation using 1H nuclear magnetic resonance
(NMR)-based metabolomics. Pregnant mice expressing Ahrd (low affinity) or Ahrb (high affinity) were fed diets containing
beta naphthoflavone (BNF), a potent AHR agonist. Mammary, serum, and
liver metabolomics analysis identified significant changes in lipid
and TCA cycle intermediates in the Ahrb mice. We observed decreased amino acid and glucose
levels in the mammary gland extracts of Ahrb mice fed BNF. The serum of BNF fed Ahrb mice had significant changes in LDL/VLDL
(increased) and HDL, PC, and GPC (decreased). Quantitative PCR analysis
revealed ∼50% reduction in the expression of key lactogenesis
mammary genes including whey acid protein, α-lactalbumin, and β-casein. We also observed morphologic and developmental disruptions in the
mammary gland that are consistent with previous reports. Our observations
support that AHR activity contributes to metabolism regulation in
the lactation network.